'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR

R. Nijveldt; A. M. Beek; A. Hirsch; M. B. M. Hofman; V. A. W. M. Umans; P. R. Algra; A. C. van Rossum

doi:10.1007/BF03086141

'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR

R. Nijveldt
, A. M. Beek
, A. Hirsch
, M. B. M. Hofman
, V. A. W. M. Umans
, P. R. Algra
, A. C. van Rossum

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Cardiovascular magnetic resonance is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction. However, limited data are available with respect to infarct size, presence and extent of microvascular injury (MVO) and changes over time, in relation to cardiac function in optimally treated patients. In the current study we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. (Neth Heart J 2008;16:179-81.)

Original language	English
Pages (from-to)	179-181
Journal	Netherlands heart journal
Volume	16
Issue number	5
DOIs	https://doi.org/10.1007/BF03086141
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/BF03086141

Cite this

@article{12717745845a4506a4d76cbdcb1a07c6,

title = "'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR",

abstract = "Cardiovascular magnetic resonance is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction. However, limited data are available with respect to infarct size, presence and extent of microvascular injury (MVO) and changes over time, in relation to cardiac function in optimally treated patients. In the current study we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. (Neth Heart J 2008;16:179-81.)",

author = "R. Nijveldt and Beek, \{A. M.\} and A. Hirsch and Hofman, \{M. B. M.\} and Umans, \{V. A. W. M.\} and Algra, \{P. R.\} and \{van Rossum\}, \{A. C.\}",

year = "2008",

doi = "10.1007/BF03086141",

language = "English",

volume = "16",

pages = "179--181",

journal = "Netherlands heart journal",

issn = "1568-5888",

publisher = "Bohn Stafleu Van Loghum",

number = "5",

}

TY - JOUR

T1 - 'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR

AU - Nijveldt, R.

AU - Beek, A. M.

AU - Hirsch, A.

AU - Hofman, M. B. M.

AU - Umans, V. A. W. M.

AU - Algra, P. R.

AU - van Rossum, A. C.

PY - 2008

Y1 - 2008

N2 - Cardiovascular magnetic resonance is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction. However, limited data are available with respect to infarct size, presence and extent of microvascular injury (MVO) and changes over time, in relation to cardiac function in optimally treated patients. In the current study we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. (Neth Heart J 2008;16:179-81.)

AB - Cardiovascular magnetic resonance is considered the standard imaging modality in clinical trials to monitor patients after acute myocardial infarction. However, limited data are available with respect to infarct size, presence and extent of microvascular injury (MVO) and changes over time, in relation to cardiac function in optimally treated patients. In the current study we prospectively investigate the change of infarct size over time, and the incidence and significance of MVO in a uniform, optimally treated patient group after AMI. (Neth Heart J 2008;16:179-81.)

U2 - 10.1007/BF03086141

DO - 10.1007/BF03086141

M3 - Article

C2 - 18566669

SN - 1568-5888

VL - 16

SP - 179

EP - 181

JO - Netherlands heart journal

JF - Netherlands heart journal

IS - 5

ER -

'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this